Whitefort Capital Management’s Arbutus Biopharma ABUS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$67.2M	Buy	14,930,885 +1,587,657	+12%	+$6.94M	20.45%	1
2025 Q4	$64.2M	Hold	13,343,228	–	–	19.42%	1
2025 Q3	$60.6M	Hold	13,343,228	–	–	20.05%	1
2025 Q2	$41.2M	Buy	13,343,228 +35,261	+0.3%	+$117K	15.95%	3
2025 Q1	$46.4M	Buy	13,307,967 +66,051	+0.5%	+$220K	21.85%	1
2024 Q4	$43.3M	Buy	13,241,916 +373,949	+3%	+$1.38M	20.72%	1
2024 Q3	$49.5M	Hold	12,867,967	–	–	22.56%	1
2024 Q2	$39.8M	Buy	12,867,967 +5,815	+0%	+$17.4K	24.51%	1
2024 Q1	$33.2M	Sell	12,862,152 -334,910	-3%	-$867K	20.21%	2
2023 Q4	$33M	Buy	13,197,062 +1,301,585	+11%	+$2.55M	21.03%	2
2023 Q3	$24.1M	Buy	11,895,477 +3,801,556	+47%	+$7.97M	14.28%	3
2023 Q2	$18.6M	Buy	8,093,921 +593,895	+8%	+$1.55M	17.48%	2
2023 Q1	$22.7M	Buy	7,500,026 +3,649,257	+95%	+$10.3M	21.12%	2
2022 Q4	$8.97M	Buy	+3,850,769	New	+$9.21M	6.97%	6